Search Orphan Drug Designations and Approvals
-
Generic Name: | dimethylaminomicheliolide Fumarate |
---|---|
Date Designated: | 11/03/2022 |
Orphan Designation: | Treatment of Diffuse Midline Glioma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Accendatech AU Pty Ltd. Suite 2903, 201 Elizabeth Street Sydney, Sydney 2000 Australia The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-